Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical Cord Stem Cell Secretions for Skin Rejuvenation
NCT06217627Phase 1Completed
- Sponsor
- COR Medicine
- Start
- Mar 2021
- Primary completion
- Jan 2023
- Countries
- 1
01
Overview
Phase 1, single-blind trial in Skin aging, sponsored by COR Medicine. Primary endpoints: Selected growth factors assessment at 1 week and Wrinkle severity in hands at 30 weeks. Started Mar 2021; status: completed.
02
Conditions
Skin aging
Beyond the preview
Go deeper on NCT06217627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06217627.